EC green lights Romania's CEC Bank recapitalisation

Business Forum
The European Commission (EC) has determined that Romania's €200 million (RON 1 billion) recapitalisation of CEC Bank, which is wholly state-owned, does not constitute state aid under EU regulations.

EU state aid rules stipulate that if a Member State acts in a way that a prudent private investor would, and is compensated for the risk in a manner acceptable to such an investor, the intervention is not considered state aid.

In September 2024, Romania notified the EC of its plan to inject capital into CEC Bank. The primary objectives of this move include boosting the bank's lending capacity, developing the CEC Financial Group, and enhancing operational efficiency through workflow improvements.

Romania provided a business plan spanning 2025-2028, a long-term outlook for 2029-2032, and a report detailing the 'private investor test', all of which were assessed by the EC. 

The Commission's analysis of Romania's business plan indicated that the capital injection is projected to generate returns in line with market conditions for the sole shareholder of CEC Bank. 

The business plan also forecasts an increase in market share for lending and deposits, improved efficiency, and strong capital levels for the bank. 

RECOMMENDED
Bellemonde launches new villa project near Bucharest
Real estate

Bellemonde launches new villa project near Bucharest

Bellemonde has announced the launch of Bellemonde Privée, a new residential project in Pipera adding 52 villas to the growing community. The total investment amounts to €25 million, with approximately 65% secured through a financing partnership with Vista Bank.

RECOMMENDED FROM THE HOME PAGE
Electro-Alfa plans IPO on BVB
Finance

Electro-Alfa plans IPO on BVB

Electro-Alfa International, a Romanian electrical equipment manufacturer, has announced plans for an Initial Public Offering (IPO) on the Bucharest Stock Exchange (BVB).

Industry

Life sciences M&A surges 81% as big pharma hunts for growth, says EY

Global life sciences M&A activity increased by 81% in 2025 to $240 billion, driven by Big Pharma's large-scale deals, despite fewer overall transactions. The surge reflects companies prioritising innovations ready for launch as they face widening growth gaps.

Finance

Romania launches first 2026 Fidelis bond IPO on stock exchange

Romania's Ministry of Finance will conduct its first public offering of Fidelis government bonds for 2026 between January 16 and 23 on the Bucharest Stock Exchange. This marks the 32nd offering since the Fidelis program resumed in July 2020.

READ MORE
Business Forum  |  16 January, 2026 at 5:00 PM
Business Forum  |  16 January, 2026 at 4:13 PM